(Q54674962)

English

Spotlight on trastuzumab as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.

scientific article published in June 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

title

Spotlight on trastuzumab as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

main subject

Erb-b2 receptor tyrosine kinase 2

1 reference

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

Lesley J Scott

series ordinal

3

object named as

Lesley J Scott

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 June 2018

2

Gillian M Keating

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

publication date

1 June 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

published in

BioDrugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

volume

24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

page(s)

207-209

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

exact match

https://scigraph.springernature.com/pub.10.2165/11204680-000000000-00000

0 references

Identifiers

DOI

10.2165/11204680-000000000-00000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

Dimensions Publication ID

1028666918

0 references

PubMed publication ID

20462285

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20462285

retrieved

2 June 2018

reference URL

http://europepmc.org/abstract/MED/20462285

(Q54674962)

Spotlight on trastuzumab as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)